These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27068456)

  • 1. A comparison of methods to adjust for continuous covariates in the analysis of randomised trials.
    Kahan BC; Rushton H; Morris TP; Daniel RM
    BMC Med Res Methodol; 2016 Apr; 16():42. PubMed ID: 27068456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorisation of continuous covariates for stratified randomisation: How should we adjust?
    Sullivan TR; Morris TP; Kahan BC; Cuthbert AR; Yelland LN
    Stat Med; 2024 May; 43(11):2083-2095. PubMed ID: 38487976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis.
    Royston P; Sauerbrei W
    Stat Med; 2014 Nov; 33(27):4695-708. PubMed ID: 25244679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
    Royston P; Sauerbrei W
    Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis.
    Royston P; Sauerbrei W
    Stat Med; 2013 Sep; 32(22):3788-803. PubMed ID: 23580422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model.
    Austin PC; Fang J; Lee DS
    Stat Med; 2022 Feb; 41(3):612-624. PubMed ID: 34806210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.
    Kahan BC; Jairath V; Doré CJ; Morris TP
    Trials; 2014 Apr; 15():139. PubMed ID: 24755011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simulation Study Comparing Different Statistical Approaches for the Identification of Predictive Biomarkers.
    Haller B; Ulm K; Hapfelmeier A
    Comput Math Methods Med; 2019; 2019():7037230. PubMed ID: 31312252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials.
    Royston P; Sauerbrei W
    Methods Inf Med; 2005; 44(4):561-71. PubMed ID: 16342923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Flexible Modeling of Continuous Covariates in Inverse-Weighted Estimators.
    Kyle RP; Moodie EEM; Klein MB; Abrahamowicz M
    Am J Epidemiol; 2019 Jun; 188(6):1181-1191. PubMed ID: 30649165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure assessment for Cox proportional hazards cure models with interval-censored survival data.
    Wang W; Cong N; Ye A; Zhang H; Zhang B
    Biom J; 2022 Jan; 64(1):91-104. PubMed ID: 34378243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cumulative incidence function under the proportional hazards model.
    Cheng SC; Fine JP; Wei LJ
    Biometrics; 1998 Mar; 54(1):219-28. PubMed ID: 9544517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response.
    Binder H; Sauerbrei W; Royston P
    Stat Med; 2013 Jun; 32(13):2262-77. PubMed ID: 23034770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of alternative smoothing methods for fitting non-linear exposure-response relationships with Cox models in a simulation study.
    Govindarajulu US; Malloy EJ; Ganguli B; Spiegelman D; Eisen EA
    Int J Biostat; 2009 Jan; 5(1):Article 2. PubMed ID: 20231865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of pharmacokinetic studies for latent covariates.
    Lagishetty CV; Coulter CV; Duffull SB
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):87-97. PubMed ID: 22161222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.